CMOP±R for untreated non-Hodgkin's lymphoma
Part of Cancer clinical trials.
This trial tests a combination of chemotherapy drugs (CMOP with or without R) for people with newly diagnosed non-Hodgkin's lymphoma who have not received treatment yet. It aims to see how well the treatment works and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been newly diagnosed with non-Hodgkin's lymphoma and have not had treatment yet.
- You have at least one tumor that can be measured on a scan (lymph node larger than 1.5 cm or other lesion larger than 1 cm).
- You are generally able to take care of yourself (ECOG score 0-2).
- Your blood counts and liver/kidney function are within acceptable ranges.
- You do not have serious heart problems, active hepatitis B or C, HIV, or other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (HSK47977) to see how it works in people with non-Hodgkin lymphoma that has come back or not responded to treatment. The goal is to understand how the drug is processed by the body, its safety, and whether it can help shrink tumors.
This trial tests a new combination of drugs (R-CMOP) for people who have just been diagnosed with a type of lymphoma called diffuse large B-cell lymphoma (DLBCL) and have not yet received any treatment for it. The goal is to see if this treatment works well and is safe.
This trial tests if a new drug combination (R-CMOP) works as well as or better than the usual combination (R-CHOP) for people with a type of lymphoma called DLBCL who haven't had treatment yet.
This trial is testing a new combination of chemotherapy drugs (CMOEP) for people with untreated Peripheral T-cell lymphoma. It aims to see if this treatment is safe and effective.
This trial studies a specific treatment plan to see how well it works for adults with newly diagnosed non-Hodgkin lymphoma that has a high amount of disease. It may help by aiming to control lymphoma more effectively, especially when it is widespread.
This trial tests whether a new combination of chemotherapy drugs (P-GEMD) works better than the standard combination (P-Gemox) for people with certain types of natural killer/T-cell lymphoma (a rare blood cancer). It's designed for newly diagnosed or advanced-stage patients who haven't been treated yet.
Hear when a new NHL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.